Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

Jewett-Cameron Posts Higher Q2 Profit

4/11/2012 8:00 PM ET

Jewett-Cameron Trading Company Ltd. (JCTCF: Quote,JCT.TO: Quote) reported net income for the second quarter of $1.3 million or $0.71 per share, compared to $496,949 or $0.25 per share for the year-ago quarter.

The latest quarter results include a reversal of litigation reserves of $1.44 million and interest expense of $16,023.

Sales for the second quarter declined to $11.75 million from $11.86 million a year earlier.

Click here to receive FREE breaking news email alerts for Jewett-Cameron Trading Co Ltd and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Chipmaker Advanced Micro Devices Inc. said Thursday after the markets closed that its first quarter loss narrowed from last year, helped by strong revenue growth in its graphics and visual solutions business. The company's quarterly earnings per share, excluding items, also came in above analysts' expectations as did its quarterly revenue. After trending higher over the past few sessions, stocks showed a lack of direction throughout the trading day on Thursday. The major averages spent the session bouncing back and forth across the unchanged line before ending the day mixed. While the major averages closed on opposite sides of the unchanged line, they all showed only modest moves. U.S. Secretary Of State John Kerry said Thursday that he and his counterparts from Russia, Ukraine and the European Union have reached an agreement on a preliminary plan for ending the ongoing crisis in Ukraine. Kerry was speaking at the end of the Ukraine contact group's first meeting, comprising the foreign ministers of Russia, Ukraine, the EU and the U.S., in the Swiss city of Geneva.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.